NCT02582203View on ClinicalTrials.gov

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

PHASE4CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Skin Diseases, InfectiousStaphylococcal Skin Infections
Interventions
DRUG

Ceftaroline

DRUG

Vancomycin

Trial Locations (3)

48201

Detroit Medical Center, Detroit

St. John Hospital and Medical Center, Detroit

48202

Henry Ford Hospital, Detroit

Sponsors
All Listed Sponsors
collaborator

Henry Ford Hospital

OTHER

collaborator

St. John Providence Health System

OTHER

collaborator

Detroit Medical Center

OTHER

collaborator

Forest Laboratories

INDUSTRY

lead

Wayne State University

OTHER